IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMEDANWAR GHANDOUR

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1932690526
CMS profile
8803438
Location
OMAHA, NE

General Payments · PY2020–2024

$1,443.83

  • Reported across 60 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$967.89

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology NE All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $832.77 45
Education $135.12 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Retrophin, Inc. $187.95 11
Boehringer Ingelheim Pharmaceuticals, Inc. $149.31 7
Otsuka America Pharmaceutical, Inc. $102.55 5
Bayer HealthCare Pharmaceuticals Inc. $98.55 6
Relypsa, Inc. $81.03 5
SCPHARMACEUTICALS INC. $66.71 3
Amgen Inc. $61.81 3
CALLIDITAS THERAPEUTICS US INC. $38.98 2
Lilly USA, LLC $36.03 2
GlaxoSmithKline, LLC. $35.17 2
Acerta Pharma LLC $32.67 2
Alexion Pharmaceuticals, Inc. $30.70 2
NXSTAGE MEDICAL, INC. $16.28 1
Fresenius USA Marketing, Inc. $15.65 1
Kyowa Kirin, Inc. $14.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $115.97 2
PY2022 $45.10 1
PY2023 $314.87 4
PY2024 $967.89 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $15.33 02/13/2024 Food and Beverage Undisputed 01/23/2026 1094044107 CMS
Alexion Pharmaceuticals, Inc. $15.37 05/29/2024 Food and Beverage Undisputed 01/23/2026 1093909796 CMS
Amgen Inc. $31.87 02/19/2024 Food and Beverage Undisputed 01/23/2026 1117561566 CMS
Amgen Inc. $14.27 10/23/2024 Food and Beverage Undisputed 01/23/2026 1117561568 CMS
Amgen Inc. $15.67 11/25/2024 Food and Beverage Undisputed 01/23/2026 1117561570 CMS
AstraZeneca Pharmaceuticals LP $16.75 06/10/2024 Food and Beverage Undisputed 01/23/2026 1104573128 CMS
AstraZeneca Pharmaceuticals LP $15.92 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104731013 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.33 02/21/2024 Food and Beverage Undisputed 01/23/2026 1086198540 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.28 04/02/2024 Food and Beverage Undisputed 01/23/2026 1086162834 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.12 05/15/2024 Food and Beverage Undisputed 01/23/2026 1086136481 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.11 06/08/2024 Food and Beverage Undisputed 01/23/2026 1086139511 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.05 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086240456 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.66 10/16/2024 Food and Beverage Undisputed 01/23/2026 1086137453 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.98 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118242192 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.32 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118242196 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.82 05/28/2024 Food and Beverage Undisputed 01/23/2026 1118242194 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.26 07/23/2024 Food and Beverage Undisputed 01/23/2026 1118242200 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.41 09/24/2024 Food and Beverage Undisputed 01/23/2026 1118242198 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.74 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118242188 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.78 11/04/2024 Food and Beverage Undisputed 01/23/2026 1118242190 CMS
CALLIDITAS THERAPEUTICS US INC. $14.59 02/21/2024 Food and Beverage Undisputed 01/23/2026 1141509817 CMS
CALLIDITAS THERAPEUTICS US INC. $24.39 07/15/2024 Food and Beverage Undisputed 01/23/2026 1141518449 CMS
Fresenius USA Marketing, Inc. $15.65 04/03/2024 Food and Beverage Undisputed 01/23/2026 1154207362 CMS
GlaxoSmithKline, LLC. $17.48 08/22/2024 Food and Beverage Undisputed 01/23/2026 1116080649 CMS
GlaxoSmithKline, LLC. $17.69 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116674865 CMS
Kyowa Kirin, Inc. $14.50 02/26/2024 Food and Beverage Undisputed 01/23/2026 1127038361 CMS
Lilly USA, LLC $16.94 08/27/2024 Food and Beverage Undisputed 01/23/2026 1135217652 CMS
Lilly USA, LLC $19.09 11/08/2024 Food and Beverage Undisputed 01/23/2026 1135263322 CMS
NXSTAGE MEDICAL, INC. $16.28 05/15/2024 Food and Beverage Undisputed 01/23/2026 1154283527 CMS
Otsuka America Pharmaceutical, Inc. $22.55 02/15/2024 Food and Beverage Undisputed 01/23/2026 1118897444 CMS
Otsuka America Pharmaceutical, Inc. $20.35 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118897446 CMS
Otsuka America Pharmaceutical, Inc. $19.82 06/11/2024 Food and Beverage Undisputed 01/23/2026 1118897448 CMS
Otsuka America Pharmaceutical, Inc. $22.04 07/24/2024 Food and Beverage Undisputed 01/23/2026 1118897450 CMS
Otsuka America Pharmaceutical, Inc. $17.79 11/05/2024 Food and Beverage Undisputed 01/23/2026 1118897452 CMS
SCPHARMACEUTICALS INC. $20.57 07/16/2024 Food and Beverage Undisputed 01/23/2026 1132287394 CMS
SCPHARMACEUTICALS INC. $27.35 08/27/2024 Food and Beverage Undisputed 01/23/2026 1132295373 CMS
SCPHARMACEUTICALS INC. $18.79 11/19/2024 Food and Beverage Undisputed 01/23/2026 1132313202 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912366 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912370 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912374 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912378 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912382 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912386 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912390 CMS
Travere Therapeutics, Inc. $16.89 03/13/2024 Education Undisputed 01/23/2026 1149912394 CMS
Travere Therapeutics, Inc. $16.96 06/18/2024 Food and Beverage Undisputed 01/23/2026 1149912398 CMS
Travere Therapeutics, Inc. $17.79 07/08/2024 Food and Beverage Undisputed 01/23/2026 1149912402 CMS
Travere Therapeutics, Inc. $18.08 08/26/2024 Food and Beverage Undisputed 01/23/2026 1149912406 CMS
Vifor Pharma, Inc. $16.86 01/22/2024 Food and Beverage Undisputed 01/23/2026 1124041024 CMS
Vifor Pharma, Inc. $14.68 01/29/2024 Food and Beverage Undisputed 01/23/2026 1124046282 CMS
Vifor Pharma, Inc. $19.14 05/01/2024 Food and Beverage Undisputed 01/23/2026 1124034478 CMS
Vifor Pharma, Inc. $16.41 08/06/2024 Food and Beverage Undisputed 01/23/2026 1124048261 CMS
Vifor Pharma, Inc. $13.94 10/14/2024 Food and Beverage Undisputed 01/23/2026 1124061542 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.